Impact of centralized evaluation of bone marrow histology in systemic mastocytosis-Reference-Cited by-同舟云学术

Impact of centralized evaluation of bone marrow histology in systemic mastocytosis

Published:2016-03-21 Issue:5 Volume:46 Page:392-397
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:Eur J Clin Invest

Author:

Jawhar Mohamad¹,Schwaab Juliana¹,Horny Hans-Peter²,Sotlar Karl²,Naumann Nicole¹,Fabarius Alice¹,Valent Peter³,Cross Nicholas C.P.⁴⁵,Hofmann Wolf-Karsten¹,Metzgeroth Georgia¹,Reiter Andreas¹

Affiliation:

1. Department of Hematology and Oncology; University Medical Centre Mannheim; Mannheim Germany

2. Institute of Pathology; Ludwig-Maximilians-University; Munich Germany

3. Department of Internal Medicine I; Division of Hematology and Ludwig Boltzmann Cluster Oncology; Medical University of Vienna; Vienna Austria

4. Wessex Regional Genetics Laboratory; Salisbury UK

5. Faculty of Medicine; University of Southampton; Southampton UK

Funder

José Carreras Leukämie-Stiftung

Austrian Science Fund

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/eci.12607/fullpdf

Reference20 articles.

1. Standards and standardization in mastocytosis: consensus statements on diagnostics, treatment recommendations and response criteria;Valent;Eur J Clin Invest,2007

2. Diagnostic criteria and classification of mastocytosis: a consensus proposal;Valent;Leuk Res,2001

3. Systemic mastocytosis in adults: 2015 update on diagnosis, risk stratification, and management;Pardanani;Am J Hematol,2015

4. The KIT D816V expressed allele burden for diagnosis and disease monitoring of systemic mastocytosis;Erben;Ann Hematol,2014

5. Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay;Kristensen;J Mol Diagn,2011

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Standardized indolent systemic mastocytosis evaluations across a health care system: implications for screening accuracy;Blood;2024-07-25

2. Approach to the patient with eosinophilia in the era of tyrosine kinase inhibitors and biologicals;Current Hematologic Malignancy Reports;2024-07-22

3. Serum chemistry profiling and prognostication in systemic mastocytosis: a registry-based study of the ECNM and GREM;Blood Advances;2024-06-05

4. Allogeneic Hematopoietic Cell Transplantation in Advanced Systemic Mastocytosis: A retrospective analysis of the DRST and GREM registries;Leukemia;2024-03-06

5. A multicenter retrospective comparison between systemic mastocytosis with t(8;21) AML and KIT mutant t(8;21) AML;Blood Advances;2024-02-15